Mr Brett J Turner, PA-C | |
7979 W Rifleman St, Boise, ID 83704-9066 | |
(208) 855-2410 | |
(208) 855-0157 |
Full Name | Mr Brett J Turner |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Experience | 23 Years |
Location | 7979 W Rifleman St, Boise, Idaho |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326067604 | NPI | - | NPPES |
P00246539 | Other | RR MEDICARE | |
194999 | Other | WA | LABOR & INDUSTRIES |
8326225 | Medicaid | WA |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Direct Orthopedic Care Llc | 2163648155 | 28 |
News Archive
Three studies published in Neurology add weight to the theory that vitamin D levels have an important effect on relapse rates and cerebral lesions in patients with multiple sclerosis.
Researchers at Johns Hopkins have zoomed in on what is going on at the molecular level when the body recognizes and defends against an attack of pathogens, and the findings, they say, could influence how drugs are developed to treat autoimmune diseases.
Scientists at the Sloan Kettering Institute have found that increased activity of a normal metabolic enzyme can lead to cancer. The enzyme, SHMT2, is a driver of a large portion of B cell lymphomas and could be a potential drug target.
Two Princeton University studies are opening important new windows into understanding an untreatable group of common genetic disorders known as RASopathies that are characterized by distinct facial features, developmental delays, cognitive impairment and heart problems.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Brett J Turner, PA-C 7979 W Rifleman St, Boise, ID 83704-9066 Ph: (208) 855-2410 | Mr Brett J Turner, PA-C 7979 W Rifleman St, Boise, ID 83704-9066 Ph: (208) 855-2410 |
News Archive
Three studies published in Neurology add weight to the theory that vitamin D levels have an important effect on relapse rates and cerebral lesions in patients with multiple sclerosis.
Researchers at Johns Hopkins have zoomed in on what is going on at the molecular level when the body recognizes and defends against an attack of pathogens, and the findings, they say, could influence how drugs are developed to treat autoimmune diseases.
Scientists at the Sloan Kettering Institute have found that increased activity of a normal metabolic enzyme can lead to cancer. The enzyme, SHMT2, is a driver of a large portion of B cell lymphomas and could be a potential drug target.
Two Princeton University studies are opening important new windows into understanding an untreatable group of common genetic disorders known as RASopathies that are characterized by distinct facial features, developmental delays, cognitive impairment and heart problems.
› Verified 4 days ago